Re: What to call it?

From: Jorge Neumann (neumann@santacasa.tche.br)
Date: Wed Jan 21 1998 - 08:34:31 EST


	Dear Dr. Anna,

		I became curious about your answer. I agree with the AML
M0 hypotesis, but have you seen M7 positive for TdT? In the very few cases
we have seen here so far thay were all TdT negatives.

Jorge Neumann
Santa Casa Hospital
Porto Alegre, Brasil

On Tue, 20 Jan 1998, Anna Porwit-MacDonald wrote:

> 
> 
> Hi,
> The immunophenotype you gave is consistent with AMLM0, but I would do the
> cyt.CD79a and CD61 just to exclude (unlikely) early-B-precursor and M7.
> Best wishes
> Anna
> 
> Anna Porwit-MacDonald
> Haematopathology Lab.
> Karolinska Hospital, Stockholm
> 
> At 12.11 1998-01-19 -0500, you wrote:
> >
> >We are discussing a case of acute leukemia with the following results:
> >Morphology - 93% undifferentiated blasts.
> >CD 45 POS(DIM), CD7 POS, HLA-DR POS, CD34 POS, CD13POS (DIM),
> >TdT POS.
> >Negative for MPO,CD2, CD3 (surface and cytoplasmic), CD4,CD8, CD19,
> >CD20, CD10, CD14,CD33.
> >Debate-Undifferentiated or MO? (or something else!!?)
> >Comments please!
> >
> >Mike Keeney
> >London Health Science Centre
> >Canada
> >
> >
> Anna Porwit-MacDonald
> Heamatopathology Lab.
> Department of Pathology
> Karolinska Hospital, Stockholm
> anpo@mb.ks.se
> tel.:+46-851775863
> fax.:+46-851775843
> 



This archive was generated by hypermail 2b29 : Wed Apr 03 2002 - 11:51:42 EST